Velo3D's Q3 Preview Shows Improvement, But Turnaround Remains Far From Certain

What happened

Velo3D's upcoming Q3 2026 report is expected to show revenue of $19.5–$20.5 million, up 43–51% year-over-year, following a Q2 where gross margin turned positive at 21.5%, a significant improvement from the 3.2% GAAP margin in Q3 2025. However, the revenue base remains too small to achieve operating leverage or breakeven, and the company still faces going-concern warnings, heavy customer concentration, and persistent liquidity needs. Its Rapid Production Solutions (RPS) business has secured AS9100D certification and multiple defense contracts (DIU, Navy, Army), but widespread commercial adoption remains elusive. The stock has been extremely volatile, currently around $14, having recently spiked on defense headlines after trading as low as $3 earlier in the year, with a history of deeply dilutive financings including a $30 million PIPE at $8.25. Management's prior targets of >30% gross margin by Q4 2025 and EBITDA breakeven in 1H 2026 now appear unrealistic, and the market continues to price in a successful turnaround that is far from assured.

Implication

The Q3 revenue growth and positive gross margin are encouraging but insufficient; until the company demonstrates several consecutive quarters of gross margin above 15–20% with meaningful RPS backlog conversion and self-funded operations, the equity remains a speculative option rather than an investment. Existing holders should use any strength to reduce exposure, given the persistent need for capital and history of deeply dilutive raises (e.g., $30M PIPE at $8.25, prior offerings at $0.35). Prospective investors should wait for either a much lower entry price (below $8) or clear evidence that defense programs have moved from prototyping to recurring production orders. Monitoring points include Q3 2026 actuals vs guidance, Q2 gross margin sustainability, RPS backlog growth, cash runway post-PIPE, and any new financing terms. The base case fair value remains around $12, but downside to $7 or lower is plausible if liquidity tightens or defense programs stall.

Thesis delta

The core thesis shifts slightly from 'POTENTIAL SELL with trim above $22' to a more cautious 'AVOID/TRIM' at present, acknowledging that gross margin has turned positive and revenue growth is accelerating but still far from scale. The prior bear case that defense awards would not translate into production is being challenged by recent wins, but the fundamental economics remain fragile, and the company's own targets appear unattainable, keeping conviction low. No change to the fundamental view that risk-reward is unfavorable for new capital until evidence of durable profitability emerges.